Phentolamine Mesylate

CHEMBL1200873 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

377.5 g/mol

LogP

—

Phase

4

A mesylate salt form of phentolamine with the same therapeutic properties. Used to treat and prevent high blood pressure episodes associated with pheochromocytoma, a tumor of the adrenal gland, by blocking receptors that cause blood vessel constriction.

Peso molecular

377,5000 g/mol

TPSA

111,00 Å²

Áreas terapéuticas

Cáncer de próstata Enfermedad pulmonar obstructiva crónica Glaucoma Hipertensión Ictus Insuficiencia cardíaca Obesidad

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1

InChI

InChI=1S/C17H19N3O.CH4O3S/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15;1-5(2,3)4/h2-8,11,21H,9-10,12H2,1H3,(H,18,19);1H3,(H,2,3,4)

Molecular Formula

C18H23N3O4S

HBD / HBA

3 / 6

Enlaces Rotables

4

Átomos Pesados

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A mesylate salt form of phentolamine with the same therapeutic properties. Used to treat and prevent high blood pressure episodes associated with pheochromocytoma, a tumor of the adrenal gland, by blocking receptors that cause blood vessel constriction.

Yes, Phentolamine Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200873. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 91430. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Phentolamine Mesylate en PillFYI

Estructura

Datos Rápidos

Fórmula: C18H23N3O4S
Sinónimos: 3

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.